Comparing a new buprenorphine treatment for opioid dependence
Part of Mental health clinical trials.
This study compares different treatments for opioid dependence, specifically looking at a new way of giving buprenorphine (a medicine that reduces cravings) versus standard treatment. If you have opioid dependence, this trial might help find a more convenient and effective treatment option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- A doctor must have confirmed that you are dependent on opioids (opioid use disorder).
- You must not be pregnant and must be able to participate in an opioid addiction treatment program.
- You must not have allergies to the study medicines (buprenorphine or methadone).
- You must not be currently taking or recently taken naltrexone (a medicine that blocks opioids).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two different forms of buprenorphine (a medication for opioid addiction) to see which works better for people who use fentanyl or other strong synthetic opioids. If you are seeking treatment for opioid use, this trial may help you find the most effective option.
This study compares two forms of a medication called buprenorphine (one is a pill you take under the tongue, the other is an injection) to see which works better for treating opioid use disorder. If you are eligible, you will receive one of these forms for a year and regular check-ups.
This study compares two medications, methadone and buprenorphine, to see which helps people stay in treatment for opioid use disorder. You may be eligible if you are starting a new treatment episode.
This study tests a new way to receive buprenorphine—a once-a-month injection—from a mobile clinic that comes to you. It aims to make treatment more convenient and acceptable for people with opioid use disorder.
This study compares two methods of starting buprenorphine (a medication that helps reduce opioid cravings and withdrawal) for people who use fentanyl daily. The goal is to see which method helps people stay in treatment longer.
This study tests a faster way to start buprenorphine (a medication for opioid use disorder) by using naloxone to briefly trigger mild withdrawal. This could help people get started on treatment more comfortably and quickly.
Hear when a new Opioid Dependence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.